Scarica l'app Stockscreener
54.30
0.33%
-0.18
Dopo l'orario di chiusura:
54.30
Precedente Chiudi:
$54.48
Aprire:
$54.49
Volume 24 ore:
1.18M
Relative Volume:
0.75
Capitalizzazione di mercato:
$7.35B
Reddito:
$2.51B
Utile/perdita netta:
$185.56M
Rapporto P/E:
40.52
EPS:
1.34
Flusso di cassa netto:
$517.59M
1 W Prestazione:
+4.64%
1M Prestazione:
-7.34%
6M Prestazione:
-41.58%
1 anno Prestazione:
-24.47%
Intervallo 1D:
$53.78
$54.78
Intervallo di 1 settimana:
$52.01
$54.78
Portata 52W:
$51.87
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Confronta GMED con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
54.30 | 7.38B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
126.35 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.84 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
400.69 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.97 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.49 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
| 2023-02-10 | Downgrade | Needham | Buy → Hold |
| 2023-02-10 | Downgrade | Truist | Buy → Hold |
| 2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-28 | Iniziato | Wells Fargo | Overweight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-29 | Iniziato | Loop Capital | Buy |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2020-12-08 | Iniziato | Citigroup | Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2020-08-06 | Reiterato | Needham | Buy |
| 2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Iniziato | Northland Capital | Market Perform |
| 2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Reiterato | Needham | Buy |
| 2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Reiterato | Needham | Buy |
| 2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Reiterato | Needham | Buy |
| 2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating - Insider Monkey
Real time social sentiment graph for Globus Medical Inc. Free ROI Driven Equity Selection With Safety - metal.it
What catalysts could drive Globus Medical Inc. stock higher in 2025Invest smarter with real-time trading alerts - jammulinksnews.com
What are Globus Medical Inc. company’s key revenue driversBest Dividend Updates From AI Tools - jammulinksnews.com
When is Globus Medical Inc. stock expected to show significant growthConsistent high-yield stocks - jammulinksnews.com
What makes Globus Medical Inc. stock price move sharplyBuild a portfolio that outperforms the market - jammulinksnews.com
Why Globus Medical Inc. stock attracts strong analyst attentionFree VIP Group - metal.it
Globus Medical Names Keith Pfeil as CEO, Posts Strong Q2 Sales Growth - MSN
Is Globus Medical Inc. a good long term investmentSuperior stock selection - PrintWeekIndia
Globus Medical Introduces DuraPro with Navigation to Enhance Surgical Workflows, Safety - MSN
What drives Globus Medical Inc. stock priceHigh-yield growth strategies - PrintWeekIndia
Orthobiologics Market Growth in Future Scope 2025-2032 | Zimmer Biomet, Bone Biologics Corp., Globus Medical - openPR.com
What analysts say about Globus Medical Inc. stockFree Predictions - jammulinksnews.com
Globus promotes Keith Pfeil to CEO as former exec leaves for Dentsply - MedTech Dive
Globus Medical Inc. Stock Analysis and ForecastFree Stock Market Mentorship - jammulinksnews.com
Globus Medical to Announce Q2 2025 Financial Results on August 7, Followed by Investor Call - MSN
Spinal Non-Fusion Technologies Market Set to Witness - openPR.com
Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns - TipRanks
Globus Medical CEO leaves for Dentsply Sirona corner office - MassDevice
Globus Medical Appoints Keith Pfeil as CEO - citybiz
Avantor and Globus Medical appoint new CEOs - The Business Journals
What You Can Learn From Globus Medical, Inc.'s (NYSE:GMED) P/E - simplywall.st
Why Globus Medical (GMED) Shares Are Trading Lower Today - TradingView
Globus Medical stock holds steady as Needham maintains rating amid CEO change - Investing.com Canada
Globus CEO leaving, analysts see replacement as steady hand - BioWorld MedTech
Globus Medical's Leadership Transition: A Strategic Catalyst for Long-Term Growth in the Medical Technology Sector - AInvest
Globus Medical's Leadership Transition and Growth Potential in a Post-Merger Landscape - AInvest
Keith Pfeil to Lead Globus Medical (GMED) as CEO from July 2025 - GuruFocus
Globus Medical stock hits 52-week low at 53.54 USD By Investing.com - Investing.com Canada
Daniel Scavilla Named CEO of Dentsply Sirona - Dentistry Today
Dentsply Sirona Hires Globus CEO Daniel Scavilla as Chief Exec - Medical Product Outsourcing
Impingement Syndrome Market Growing with Musculoskeletal - openPR.com
Globus Medical Announces New CEO and CFO - TipRanks
Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth By Investing.com - Investing.com South Africa
Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth - Investing.com Nigeria
Dentsply Sirona Appoints Daniel Scavilla as President and CEO, Effective August 1, 2025 - Quiver Quantitative
Globus Medical sees Q2 revenue $745.3M, consensus $738.91M - TipRanks
Globus Medical (GMED) Posts Strong Sales Growth in Q2 2025 | GME - GuruFocus
Former Globus Medical CEO Takes Helm at Dentsply Sirona as Q2 Sales Hit $935M - Stock Titan
Globus Medical's Leadership Transition and Q2 Sales Performance: A Strategic Blueprint for Sustained Growth in Musculoskeletal Tech - AInvest
Globus Medical Appoints Keith Pfeil as New President and CEO, Carl Kline as CFO - Quiver Quantitative
Globus Medical Expands Surgical Navigation Portfolio With Advanced DuraPro Oscillating System - MSN
GMED names new CEO & CFO after sudden resignation – compensation, details - Stock Titan
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results - GlobeNewswire
Globus Medical Shakes Up Leadership: New CEO Takes Helm as Q2 Sales Hit Record $745M, Up 18% - Stock Titan
Globus Medical Inc Azioni (GMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
1.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):